Autoantibodies to citrullinated proteins: ACPA

References

• Nienhuis RLF, Mandema E, Smids C. A new serum factor in patients with rheumatoid arthritis, the antiperinuclear factor. Ann Rheum Dis 1964;23:302–305.
   PubMed Web of Science ®Google Scholar
• Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ. Anti-keratin antibodies in rheumatoid arthritis. Br Med J 1979;2:97–99.
   Google Scholar
• Youinou P, Serre G. The antiperinuclear factor and antikeratin antibody systems. Int Arch Allergy Immunol 1995;107:508–518.
   PubMedGoogle Scholar
• Vincent C, Serre G, Lapeyre F, Fournié B, Ayrolles C, Fournié A, et al. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called "antikeratin antibodies". Ann Rheum Dis 1989;48: 712–722.
   PubMed Web of Science ®Google Scholar
• Aho K, von Essen R, Kurki P, Palosuo T, Heliovaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 1993;20:1278–1281.
   PubMed Web of Science ®Google Scholar
• Mallya RK, Young BJ, Pepys MB, Hamblin TJ, Mace BE, Hamilton EB. Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease. Clin Exp Immunol 1983;51:17–20.
   PubMed Web of Science ®Google Scholar
• Meyer O, Fabregas D, Cyna L, Ryckewaert A. Les anticorps antikératine. Un marqueur des polyarthrites rhumatoides évolutives. Rev Rheum 1986;53:601–605.
   Google Scholar
• Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M. Antikeratin antibodies: diagnostic and pronostic markers for early rheumatoid arthritis. Ann Rheum Dis 1992;51:743–746.
   PubMed Web of Science ®Google Scholar
• Forslind K, Vincent C, Serre G, Svensson B. Antifilaggrin antibodies in early rheumatoid arthritis may predict radiologi-cal progression. Scand J Rheumatol 2001;30:221–224.
   PubMedGoogle Scholar
• Simon M, Girbal E, Sebbag M, Gomés-Daudrix V, Vincent C, Salama G, et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies", autoantibodies specific for rheumatoid arthritis. J Clin Investig 1993;92: 1387–1393.
   Google Scholar
• Girbal E, Sebbag M, Gomès-Daudrix V, Simon M, Vincent C, Serre G. Characterization of the rat oesophagus epithelium antigens defined by the so-called "antikeratin antibodies", specific for rheumatoid arthritis. Ann Rheum Dis 1993;52: 749–757.
   PubMed Web of Science ®Google Scholar
• Sebbag M, Simon M, Vincent C, Masson-Bessiére C, Girbal E, Durieux JJ, et al. The antiperinuclear factor and the so-called "antikeratin antibodies" are the same rheumatoid arthritis-specific autoantibodies. J Clin Investig 1995;95:2672–2679.
   Google Scholar
• Schellekens GA, de Jong BA, Van den Hoogen FH, Van de Putte LB, Van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheuma-toid arthritis-specific autoantibodies. J Clin Investig 1998;101:273–281.
   PubMed Web of Science ®Google Scholar
• Girbal-Neuhauser E, Durieux jj, Arnaud M, Dalbon P, Sebbag M, Vincent C, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are post-translationally generated on various sites of (pro)-filaggrin by deimination of arginine residues. J Immunol 1999;162:585–594.
   Google Scholar
• Després N, Boire G, Lopez-Longo FJ, Ménard HA. The Sa system: a novel antigen-antibody system specific for rheuma-toid arthritis. J Rheumatol 1994;21:1027–1033.
   Google Scholar
• Vossenaar ER, Despres N, Lapointe E, Van der Heijden A, Lora M, Senshu T, et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004;6:142–150.
   Google Scholar
• Masson-Bessiére C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G. The major synovial targets of the rheumatoid arthritis-specific antifilag-grin autoantibodies are deiminated forms of the a- and 13-chains of fibrin. J Immunol 2001;166: 4177–4184.
   Google Scholar
• Masson-Bessière C, Sebbag M, Durieux JJ, Nogueira L, Vincent C, Girbal-Neuhauser E, et al. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000;119:544–552.
   Google Scholar
• Vincent C, Serre G, Basile JP, Lestra HC, Girbal E, Sebbag M, Soleilhavoup JP. Subclass distribution of IgG antibodies to the rat oesophagus stratum corneum (so-called antikeratin antibodies) in rheumatoid arthritis. Clin Exp Immunol 1990;81:83–89.
   Google Scholar
• Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol (in press).
   Google Scholar
• Vincent C, de Keyser F, Masson-Bessière C, Sebbag M, Veys EM, Serre G. Antiperinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis 1999;58: 42–48.
   Google Scholar
• Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux JJ, Cantagrel A, et al. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol 1998;25:838–846.
   Google Scholar
• Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, et al. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol 1998;115:294–302.
   PubMed Web of Science ®Google Scholar
• Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournié B, Cantagrel A, et al. Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity-purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis 2001;60:882–887.
   Google Scholar
• Union A, Meheus L, Humbel RL, Conrad K, Steiner G, Moereels H, et al. Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay. Arthritis Rheum 2002;46:1185–1195.
   PubMedGoogle Scholar
• Gomés-Daudrix V, Sebbag M, Girbal E, Vincent C, Simon M, Rakotoarivony J, et al. Immunoblotting detection of the so-called "antikeratin antibodies": a new assay for the diagnosis of rheumatoid arthritis. Ann Rheum Dis 1994;53: 735–742.
   PubMedGoogle Scholar
• Vincent C, Nogueira L, Sebbag M, Chapuy-Regaud S, Arnaud M, Letourneur O, et al. Detection of antibodies todeiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 2002;46: 2051–2058.
   Google Scholar
• Schellekens GA, Visser H, de Jong BA, Van den Hoogen FH, Hazes JM, Breedveld FC, Van Venrooij WJ. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155–163.
   PubMed Web of Science ®Google Scholar
• Vossenaar ER, Van Venrooij WJ. Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis. Clin Appl Immunol Rev 2004;:239–262.
   Google Scholar
• Nogueira L, Foussadier A, Vincent C, Clavel C, Moinard N, Jolivet M, Serre G. VIDAS-EDRA fully automated testing of autoantibodies to citrullinated proteins for the diagnosis of rheumatoid arthritis diagnosi. 24th European Workshop for Rheumatology Research, BERLIN, February 2004. Arthritis Res 20042004;6\(Suppl. 1):A14 [Abst].
   Google Scholar
• Nogueira L, Sebbag M, Chapuy-Regaud S, Clavel C, FourniéB, Cantagrel A, et al. Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for the diagnosis of rheumatoid arthritis. 22nd European Workshop for Rheumatology Research, LEIDEN, February 2002. Arthritis Res 2002;4\(Suppl 1):A30 [Abst].
   Google Scholar
• Nogueira L, Chapuy-Regaud S, Constantin A, Clavel C, Sebbag M, Cantagrel A. Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for early rheumatoid arthritis diagnosis. 23rd European Workshop for Rheumatology Research, MARSEILLE, February 2003. Arthritis Res 2003;5 (Suppl 1):A18 [Abst].
   Google Scholar
• Suzuki K, Sawada T, Murakami A, Matsui T, Tohma S, Nakazono K, et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 2003;32:197–204.
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Chin Chem 2001;47:1089–1093.
   Google Scholar
• Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxf) 2002;41:809–814.
   Google Scholar
• Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. J Rheumatol 2003;30:1451–1455.
   Google Scholar
• Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003;62:870–874.
   PubMed Web of Science ®Google Scholar
• Girelli F, Foschi FG, Bedeschi E, Calderoni V, Stefanini GF, Martinelli MG. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Allergy Immunol (Paris) 2004;36:127–130.
   Google Scholar
• Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, YarboroC, Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236–243.
   Google Scholar
• Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chales G, le Henaff C, et al. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. J Rheumatol 2003;30:2535–2539.
   Google Scholar
• Nielen MM, Van Schaardenburg D, Reesink HW, Van de Stadt RJ, Van der Horst-Bruinsma IE, de Koning MH, et al. A specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380–386.
   Google Scholar
• Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wade11 G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict thedevelopment of rheumatoid arthritis. Arthritis Rheum 2003;48:2741–2749.
   Google Scholar
• de Rycke L, Peene I, Hoffman IEA, Kruithof E, Union A, Meheus L. Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associa-tions with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 2004 (in press).
   Google Scholar
• Jansen AL, Van der Horst-Bruinsma I, Van Schaardenburg D, Van de Stadt RJ, de Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differen-tiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002;29:2074–2076.
   Google Scholar
• Kroot EJ, de Jong BA, Van Leeuwen MA, Swinkels H, Van den Hoogen FH, van't Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000; 43:1831–1835.
   Google Scholar
• Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003;62:120–126.
   Google Scholar
• Jansen LM, Van Schaardenburg D, Van der Horst-Bruinsma I, Van der Stadt RJ, de Koning MH, Dijkmans BA. The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. J Rheumatol 2003;30:1691–1695.
   Google Scholar
• Bas S, Genevay S, Meyer O, Gabay C. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumato-logy (Oxf) 2003;42:677–680.
   Google Scholar
• Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzickova S. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003;62:427–430.
   PubMed Web of Science ®Google Scholar
• Van Jaarsveld CH, ter Borg EJ, Jacobs JW, Schellekens GA, Gmelig-Meyling FH, Van Booma-Frankfort C, et al. The prognostic value of the antiperinuclear factor, anti-citrulli-nated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Chin Exp Rheumatol 1999;17:689–697.
   Google Scholar
• Van Gaalen FA, Linn-Rasker SP, Van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospec-tive cohort study. Arthritis Rheum 2004;50:709–715.
   PubMed Web of Science ®Google Scholar
• Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA 1989;86:10049–10053.
   PubMed Web of Science ®Google Scholar
• Cornélis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998;95:10746–10750.
   Google Scholar
• Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003;34:395–402.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998;95:8227–8232.
   PubMed Web of Science ®Google Scholar
• Altschuler EL. Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning. Lancet 1999;354:1026–1027.
   PubMedGoogle Scholar
• Balandraud N, Meynard JB, Auger I, Sovran H, Mugnier B, Reviron D, et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quanti-fication using real-time polymerase chain reaction. Arthritis Rheum 2003;48:1223–1228.
   PubMed Web of Science ®Google Scholar